儿童原发性二尖瓣手术结局:一项双中心研究
该双中心研究纳入1987至2023年因原发性二尖瓣病变接受手术的109例患儿,排除房室间隔缺损及单心室生理。结果显示5年生存率83.2±4.0%,5年再手术和置换累积发生率分别为27.0±4.7%和16.5±4.0%,二尖瓣狭窄表型预后较差。
要点
- 儿童原发性二尖瓣手术5年生存率83.2±4.0%,二尖瓣狭窄表型再手术风险更高。
- 术后5年再手术和置换累积发生率分别为27.0±4.7%和16.5±4.0%。
- 婴儿期修复、二尖瓣狭窄表型及早期再修复是远期再手术的预测因素。
核心结论
- 儿童原发性二尖瓣手术虽具挑战性,但超过90%可实现可接受的修复效果。
- 修复时的年龄是临床结局的强预测因素,而修复耐久性同样取决于二尖瓣病变类型,狭窄表型预后更差。
研究设计与样本
- 双中心协作回顾性研究,纳入1987至2023年所有接受原发性二尖瓣手术的儿童。
- 排除房室间隔缺损和单心室生理患者,共109例患者接受158次手术。
- 研究终点为生存率及二尖瓣再手术和/或置换需求,包括多变量风险因素分析。
主要发现
- 109例患者中,二尖瓣反流82例(74.5%),中位年龄5.7岁(IQR 1.6-12);二尖瓣狭窄27例(25.5%),中位年龄0.6岁(IQR 0.3-1.2)(p < 0.001)。
- 49例(45.0%)患者同期行相关心脏手术;103例(94.5%)初次修复成功,但需10例早期再干预(4例再修复和6例置换)。
- 总体5年生存率为83.2±4.0%,二尖瓣病变表型间无差异(p = 0.871)。
- 5年二尖瓣再手术和置换累积发生率分别为27.0±4.7%和16.5±4.0%,狭窄表型更差。
- 死亡风险因素包括生命第一年内行二尖瓣修复、同期心内矫治、关胸或需ECMO;远期再手术或置换的显著预测因素包括婴儿期修复、狭窄表型、使用交界切开或Alfieri修复及需早期二尖瓣再修复。
临床怎么用
- 对于儿童原发性二尖瓣病变,应认识到修复的挑战性及较高再手术风险,尤其对狭窄表型和婴儿期修复患者需加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Due to heterogenous mitral valve(MV) disease expression, primary MV surgery in children might be challenging, entailing suboptimal results. METHODS: In this bi-centric collaboration all children undergoing primary MV surgery from 1987 to 2023 were included. Patients with atrioventricular septal defect and univentricular physiology were excluded. Study end-points were survival and need for MV reoperation and/or replacement, including multivariable risk factor analysis. RESULTS: Overall 109 patients underwent 158 procedures for predominantly mitral regurgitation(MR)(n = 82, 74.5%) and stenosis(MS)(n = 27, 25.5%), respectively at a median age of 5.7y(IQR 1.6-12) and 0.6y(IQR 0.3-1.2)(p < 0.001). Associated cardiac procedures were performed in 49(45.0%) patients. Primary repair was successful in 103(94.5%) patients, but required 10 early reinterventions(4 re-repair and 6 replacement). Overall 5-year survival was 83.2±4.0% without difference between MV phenotypes(p = 0.871). Risk factors for mortality were MV repair in the first year of life, associated intracardiac correction, and open chest or need for ECMO at completion of surgery. The cumulative incidence of MV reoperation and replacement at 5 years were respectively 27.0±4.7% and 16.5±4.0%, in disadvantage of MS phenotype. MV repair during infancy, MS phenotype, use of commissural or Alfieri-repair and the need for early MV re-repair were significant predictors for later MV reoperation or replacement. CONCLUSION: Although primary mitral valve surgery in children remains challenging, an acceptable repair is achievable in more than 90%. Whereas younger age at repair is a strong predictor of clinical outcome, repair durability is equally depending on the type of MV disease in disadvantage of the stenosis phenotype.
引用
- Poncelet A, Rubay J, El Khoury G, et al. Outcome of primary mitral valve surgery in pediatric patients: Results from a bi-centric study. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 42723615. doi:10.1093/icvts/ivag250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。